missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Thioredoxin 80 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Marca: R&D Systems™ 2329-TX-100
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Measured by its ability to induce IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC) in the presence of IL-2. Pekkari, K. et al. (2001) Blood 97:3184. The ED50 for this effect is 0.150-1.50 μg/mL in the presence of 8 ng/mL of recombinant human IL-2.Especificaciones
| Lyophilized from a 0.2μm filtered solution in Tris, EDTA and DTT. | |
| 9 kDa (monomer) | |
| 100 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| <0.50 EU / 1 μg of the protein by the LAL method. | |
| Recombinant |
| 7295 | |
| Thioredoxin-80 | |
| E. coli-derived human Thioredoxin-80 protein Val2-Lys81 | |
| Noncovalently-linked homodimer | |
| Unconjugated | |
| >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido